NCT04503148View on ClinicalTrials.gov

Anesthesia and Cancer Study: Renal Cell Carcinoma

NAActive, not recruitingINTERVENTIONAL
Enrollment

562

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

December 22, 2022

Study Completion Date

December 22, 2025

Conditions
Renal Cell Carcinoma
Interventions
DRUG

Propofol

Propofol 1-2 mg/kg bolus injection for induction of anesthesia propofol continuous infusion for maintenance of anesthesia

DRUG

Inhaled General Anesthetics

Sevoflurane or desflurane for induction and maintenance of anesthesia

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER